Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival.
Abstract | BACKGROUND & AIMS: METHODS: Five hundred forty-nine patients with advanced (Pugh B or C) alcoholic cirrhosis were randomized to receive either colchicine 0.6 mg twice per day (n = 274) or placebo (n = 275). Treatment lasted from 2 to 6 years. The primary outcome was all-cause mortality. Secondary outcomes were liver-related morbidity and mortality. Liver biopsy was requested prior to entry and after 24 months of treatment. RESULTS: Attendance at scheduled clinic visits and adherence with study medication were similar in colchicine and placebo groups. Alcohol intake was less than 1 drink per day in 69% of patients. In an intention-to-treat analysis, all-cause mortality was similar in colchicine (49%) and placebo (45%) patients (P = .371). Mortality attributed to liver disease was 32% in colchicine and 28% in placebo patients (P = .337). Fewer patients receiving colchicine developed hepatorenal syndrome. In 54 patients with repeat liver biopsies after 24 or more months of treatment, cirrhosis improved to septal fibrosis in 7 patients (3 colchicine, 4 placebo) and to portal fibrosis in 1 patient ( colchicine). CONCLUSIONS:
|
Authors | Timothy R Morgan, David G Weiss, Bernard Nemchausky, Eugene R Schiff, Bhupinder Anand, Francis Simon, Jayashri Kidao, Bennet Cecil, Charles L Mendenhall, Douglas Nelson, Charles Lieber, Marcos Pedrosa, Lennox Jeffers, John Bloor, Lawrence Lumeng, Luis Marsano, Craig McClain, Girish Mishra, Brent Myers, Maria Leo, Yelena Ponomarenko, Derek Taylor, Antonio Chedid, Samuel French, Gary Kanel, Natalie Murray, Paul Pinto, Tse-Ling Fong, Mike R Sather |
Journal | Gastroenterology
(Gastroenterology)
Vol. 128
Issue 4
Pg. 882-90
(Apr 2005)
ISSN: 0016-5085 [Print] United States |
PMID | 15825072
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
|
Topics |
- Colchicine
(therapeutic use)
- Double-Blind Method
- Female
- Humans
- Liver
(drug effects, pathology)
- Liver Cirrhosis, Alcoholic
(drug therapy, epidemiology, mortality, pathology)
- Male
- Middle Aged
- Morbidity
- Survival Analysis
- Treatment Failure
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|